Clinical Trial Update: Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing [Phase 3]

View source ↗

Summary

This trial update describes a continued access study for participants who benefit from Pfizer-sponsored avelumab parent studies that are closing, across multipl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Ovarian Cancer
• Urothelial Carcinoma

Drugs mentioned

• BAVENCIO (AVELUMAB)

Snippet

Sponsor: Pfizer | Conditions: Advanced Malignancies, NSCLC | Phase 3 | Status: ACTIVE_NOT_RECRUITING